| James H Lott Iii, MD | |
|
817 Princeton Ave Sw, Ste 115, Birmingham, AL 35211-1333 | |
| (205) 780-1963 | |
| (205) 780-1967 |
| Full Name | James H Lott Iii |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 35 Years |
| Location | 817 Princeton Ave Sw, Birmingham, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639285802 | NPI | - | NPPES |
| 51028133 | Other | AL | BLUE CROSS OF AL |
| 000028133 | Medicaid | AL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0200X | Internal Medicine - Critical Care Medicine | 18955 (Alabama) | Secondary |
| 207RP1001X | Internal Medicine - Pulmonary Disease | 18995 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Princeton Baptist Medical Center | Birmingham, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Baptist Health Centers Llc | 3476457011 | 156 |
News Archive
Scientists working in the Academy-funded Research Programme on Neuroscience (NEURO) have discovered important changes in the way that infants react to another person's face at age 5-7 months.
Researchers from Joslin Diabetes Center, Boston, and ActiveSite Pharmaceuticals, Inc., San Francisco, announced today that they have demonstrated that a specific inhibitor of the protease plasma kallikrein, ASP-440, developed by ActiveSite Pharmaceuticals, may provide a new therapeutic approach for treatment of diabetic retinopathy, the most common eye-related complication of diabetes.
Researchers added a scaffold/matrix attachment region (S/MAR) to a conventional adeno-associated virus (AAV) vector used for gene transfer, and the modified vectors were able to establish colonies and maintain long-term transgene expression in HeLa cells, as reported in Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
According to a new report substituting pharmaceutical antidepressants with St John's Wort could save the health system $50 million a year. This research was conducted by Access Economics for the National Institute of Complementary Medicine (NICM) at the University of Western Sydney. It showed that cost effectiveness of complementary and alternative therapies have the potential to cut costs without compromising patient outcomes.
The Ontario Hospital Association (OHA) is encouraged by the Ministry of Health and Long-Term Care's announcement to expand its Emergency Room (ER) Pay for Results Program. The OHA considers this expansion a positive step forward in improving both access to care and health system accountability.
› Verified 8 days ago
| Entity Name | Baptist Health Centers Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265496236 PECOS PAC ID: 3476457011 Enrollment ID: O20180124001442 |
News Archive
Scientists working in the Academy-funded Research Programme on Neuroscience (NEURO) have discovered important changes in the way that infants react to another person's face at age 5-7 months.
Researchers from Joslin Diabetes Center, Boston, and ActiveSite Pharmaceuticals, Inc., San Francisco, announced today that they have demonstrated that a specific inhibitor of the protease plasma kallikrein, ASP-440, developed by ActiveSite Pharmaceuticals, may provide a new therapeutic approach for treatment of diabetic retinopathy, the most common eye-related complication of diabetes.
Researchers added a scaffold/matrix attachment region (S/MAR) to a conventional adeno-associated virus (AAV) vector used for gene transfer, and the modified vectors were able to establish colonies and maintain long-term transgene expression in HeLa cells, as reported in Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
According to a new report substituting pharmaceutical antidepressants with St John's Wort could save the health system $50 million a year. This research was conducted by Access Economics for the National Institute of Complementary Medicine (NICM) at the University of Western Sydney. It showed that cost effectiveness of complementary and alternative therapies have the potential to cut costs without compromising patient outcomes.
The Ontario Hospital Association (OHA) is encouraged by the Ministry of Health and Long-Term Care's announcement to expand its Emergency Room (ER) Pay for Results Program. The OHA considers this expansion a positive step forward in improving both access to care and health system accountability.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| James H Lott Iii, MD 1445 Ross Ave Ste 1400, Dallas, TX 75202-2703 Ph: (469) 893-2065 | James H Lott Iii, MD 817 Princeton Ave Sw, Ste 115, Birmingham, AL 35211-1333 Ph: (205) 780-1963 |
News Archive
Scientists working in the Academy-funded Research Programme on Neuroscience (NEURO) have discovered important changes in the way that infants react to another person's face at age 5-7 months.
Researchers from Joslin Diabetes Center, Boston, and ActiveSite Pharmaceuticals, Inc., San Francisco, announced today that they have demonstrated that a specific inhibitor of the protease plasma kallikrein, ASP-440, developed by ActiveSite Pharmaceuticals, may provide a new therapeutic approach for treatment of diabetic retinopathy, the most common eye-related complication of diabetes.
Researchers added a scaffold/matrix attachment region (S/MAR) to a conventional adeno-associated virus (AAV) vector used for gene transfer, and the modified vectors were able to establish colonies and maintain long-term transgene expression in HeLa cells, as reported in Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
According to a new report substituting pharmaceutical antidepressants with St John's Wort could save the health system $50 million a year. This research was conducted by Access Economics for the National Institute of Complementary Medicine (NICM) at the University of Western Sydney. It showed that cost effectiveness of complementary and alternative therapies have the potential to cut costs without compromising patient outcomes.
The Ontario Hospital Association (OHA) is encouraged by the Ministry of Health and Long-Term Care's announcement to expand its Emergency Room (ER) Pay for Results Program. The OHA considers this expansion a positive step forward in improving both access to care and health system accountability.
› Verified 8 days ago
Juan Mario Bernal, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3680 Grandview Pkwy Ste 200, Birmingham, AL 35243 Phone: 205-971-7500 | |
Dr. William Randolph Maddox, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 701 Princeton Ave Sw, Birmingham, AL 35211 Phone: 205-783-3000 Fax: 205-297-9411 | |
Jodie Ann Dionne, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 703 19th St S Bldg 206, Birmingham, AL 35233 Phone: 205-975-6530 | |
Dr. Karl Tullio Schroeder, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 817 Princeton Ave Sw Ste 199, Birmingham, AL 35211 Phone: 205-780-1920 Fax: 205-780-2345 | |
Dr. Deepti Bahl, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2000 6th Ave S, Birmingham, AL 35233 Phone: 205-934-9999 | |
Amitkumar Mehta, Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1720 2nd Ave S # Np2540t, Birmingham, AL 35294 Phone: 205-996-8400 Fax: 205-934-1608 | |
Shana Monika Machado, D.O. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 619 19th St S, Birmingham, AL 35249 Phone: 205-934-4011 |